Why the market leader in umami acquired a Central Ohio gene therapy startup


We talked to an executive and an investor about the somewhat surprising deal for the young company.

Previous East Bay company's 'greatest biotech comeback' drives toward drug approval in rare liver disease
Next A day after leaving Dish Network, CEO starts as head of real estate giant